TABLE 1.
Univariate and multivariate analyses of factoring affecting the OS of patients with CC based on Cox proportional hazards models including the expression of glycolytic genes explored with the HG‐1.0 ST microarray and FIGO clinical stage.
Covariates | n | Univariate analysis g | Multivariate analysis h | ||||
---|---|---|---|---|---|---|---|
HR d | 95% CI | p e | HR b | 95% CI | p e | ||
FIGO | |||||||
≤IIA | 29 | 1.0 | 1.0 | ||||
≥IIB | 32 | 3.4 | 1.1–10.4 | 3.6 × 10−2 | 3.3 d | 1.1–9.6 d | 3.5 × 10−2 f |
Glycolytic gene expression profile | |||||||
FC <1.98 a | 57 | 1.0 | 1.0 | ||||
FC≥1.98 | 4 | 8.6 | 2.7–28.0 | 3.2 × 10−4 | 5.8 | 1.7–20.2 | 5.0 × 10−3 |
Glycolysis FC score b | 61 | 5.0 | 1.1–22.3 | 3.6 × 10−2 | 3.2 | 1.0–14.5 | 1.2 × 10−2 |
LDHA | |||||||
Low c | 40 | 1.0 | 1.0 | ||||
High | 21 | 3.1 | 1.1–8.3 | 2.7 × 10−2 | 3.0 | 1.1–8.19 | 2.9 × 10−2 |
PFKP | |||||||
Low | 32 | 1.0 | 1.0 | ||||
High | 29 | 3.5 | 1.1–10.9 | 3.0 × 10−2 | 3.4 | 1.1–10.5 | 3.5 × 10−2 |
TPI1P1 | |||||||
Low | 52 | 1.0 | 1.0 | ||||
High | 9 | 3.7 | 1.3–10.9 | 1.5 × 10−3 | 2.6 | 0.8–7.87 | 4.0 × 10−2 |
GAPDH | |||||||
Low | 54 | 1.0 | 1.0 | ||||
High | 7 | 5.6 | 1.9–16.3 | 2.0 × 10−3 | 4.0 | 1.3–12.3 | 5.2 × 10−2 |
GPI | |||||||
Low | 19 | 1.0 | 1.0 | ||||
High | 42 | 8.5 | 1.1–64.1 | 3.9 × 10−2 | 7.9 | 1.0–60.0 | 5.6 × 10−2 |
ENO | |||||||
Low | 21 | 1.0 | 1.0 | ||||
High | 40 | 9.2 | 1.2–69.5 | 3.2 × 10−2 | 7.3 | 0.9–56.4 | 5.6 × 10−2 |
PGK1 | |||||||
Low | 44 | 1.0 | 1.0 | ||||
High | 17 | 2.8 | 1.0–7.6 | 3.7 × 10−2 | 2.3 | 0.9–6.2 | 1.1 × 10−1 |
ALDOA | |||||||
Low | 15 | 1.0 | 1.0 | ||||
High | 46 | 5.8 | 0.7–44.3 | 8.7 × 10−2 | 4.9 | 0.6–37.6 | 1.2 × 10−1 |
Abbreviations: CI, confidence interval; FIGO stage, International Federation of Gynecology and Obstetrics stage; HR, hazard ratio.
Optimal cutoff values were selected according to the ROC curve of the glycolysis FC score.
The analysis was performed considering the glycolysis FC score as continuous variable.
Optimal cutoff values were selected according to the ROC analysis in relation to fold changes in genes expression obtained with the Human Gene 1.0 ST microarray.
Adjusted hazard ratio.
Cox proportional hazards model.
These calculations were obtained in the multivariate analysis performed with LDHA. The values of FIGO obtained in the multivariate analysis with the other markers are not shown but are similar to these values.
Univariate analysis was performed considering one variable for the analysis.
Multivariate analysis was performed considering gene expression and FIGO stage for the analysis.